Clinical Significance of Falsely Elevated Vancomycin Concentrations in End-Stage Renal Disease

Follin SL Mueller BA Scott MK Carfagna MA Kraus MA . Falsely elevated serum vancomycin concentrations in hemodialysis patients. Am J Kidney Dis 1996;27:67–74.

Sanders NJ Want SV Adams DJ . Assay of vancomycin by fluorescence polarisation immunoassay and EMIT in patients with renal failure. J Antimicrob Chemother 1995;36:411–5.

White LO Edwards R Holt HA Lovering AM Finch RG Reeves DS . The in-vitro degradation at 37 °C of vancomycin in serum, CAPD fluid and phosphate buffered saline. J Antimicrob Chemother 1988;22:739–45.

Varaldo PE Debbia E Schito GC . In-vitro effects of vancomycin and refampicin, alone and in combination against methicillin-sensitive and methicillin-resistant staphylococci. J Antimicrob Chemother 1984;14 (suppl D):35–41.

Matzke GR . Pharmacotherapeutic consequences of recent advances in hemodialysis therapy. Ann Pharmacother 1994;28:512–4.

Najjar TA Al-Dhuwailie AA Tekle A . Comparison of high performance liquid chromatography with fluorescence polarization immunoassay for the analysis of vancomycin in patients with chronic renal failure. J Chromatogr Biomed Appl 1995;672:295–9.

Smith PF Petros WP Soucie MP Copeland KR . Falsely elevated vancomycin concentrations in ESRD: lack of cross-reactivity with a recently modified FPIA assay (abstract). American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ, November 12, 1997.